Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway

Cancer Chemotherapy and Pharmacology

Volumn 53, Issue 1, 2004, Pages 82-88

  Zhang, Xian Ming ^a   Huang, Shao Peng ^a   Xu, Qiang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Invasion; Melanoma B16 Bl6 cells; MMP; PKC; Quercetin

Indexed keywords

CHLORPROMAZINE; DOXORUBICIN; FATTY ACID; GELATIN; GELATINASE A; GELATINASE B; PHORBOL DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; QUERCETIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL COUNT; CELL MIGRATION; COMPUTER PROGRAM; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ZYMOGRAPHY;

ANIMALS; CELL ADHESION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MATRIX METALLOPROTEINASE 9; MELANOMA; MICE; NEOPLASM INVASIVENESS; QUERCETIN; TUMOR CELLS, CULTURED;

EID: 0742286824     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0702-0     Document Type: Article

References (41)

1. Crowe DL, Shuler CF (1999) Regulation of tumor cell invasion by extracellular matrix. Histol Histopathol 14:165
2. Saiki I (1997) Cell adhesion molecules and cancer metastasis. Jpn J Pharmacol 75:215
3. Kleiner DE, Stetler Stevenson WG (1999) Matrix metalloproteinase and metastasis. Cancer Chemother Pharmacol [Suppl] 43:S42
4. Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781
5. Xu J, Benyon RC, Leir SH, Zhang S, Holgate ST, Lackie PM (2002) Matrix metalloproteinase-2 from bronchial epithelial cells induces the proliferation of subepithelial fibroblasts. Clin Exp Allergy 32:881
6. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134
7. Okada N, Ishida H, Murata N, Hashimoto D, Seyama Y, Kubota S (2001) Matrix metalloproteinase-2 and 9 in bile as a marker of liver metastasis in colorectal cancer. Biochem Biophys Res Commun 288:212
8. Lengyel E, Schmalfeldt B, Konik E, Spathe K, Harting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W (2001) Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol 82:291
9. Rasmussen HS, McCann PP (1997) Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 75:69
10. Macaulay VM, O'Byrne KJ, Saunders MP, Braybrooke JP, Long L, Gleeson F, Mason CS, Harris AL, Brown P, Talbot DC (1999) Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions. Clin Cancer Res 5:513
11. King J, Zhao J, Clingan P, Morris D (2003) Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastasis: significant survival advantage in patients with musculoskeletal side-effects. Anticancer Res 23:639
12. Quirt I, Bodurth A, Lohmann R, Rusthoven J, Belanger K, Yong V, Wainman N, Stewar W, Eisenhauer E, National Cancer Institute of Canada Clinical Trials Group (2002) Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Group. Invest New Drugs 20:431
13. Caponigro F, French RC, Kaye SB (1997) Protein kinase C: a worthwhile target for anticancer drugs? Anticancer Drugs 8:26
14. Blobe GC, Obeid LM, Hannun YA (1994) Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev 13:411
15. Zeidman R, Pettersson L, Sailaja PR, Truedsson E, Fagerstrom S, Pahlman S, Larsson C (1999) Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells. Int J Cancer 8:494
16. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:784
17. + ions. Eur J Biochem 102:615
18. Hallaq H, Smith TW, Leaf A (1992) Modulation of dihydropyridine- sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U S A 89:1760
19. Hannun YA, Foglesong RJ, Bell RM (1989) The adriamycin-iron (III) complex is a potent inhibitor of protein kinase C. J Biol Chem 264:9960
20. Zhao FK, Chuang LF, Israel M, Chuang RY (1989) Adriamycin interacts with diacylglycerol to inhibit human leukemia protein kinase C. Anticancer Res 9:225
21. Sanchez A, Hallam TJ, Rink TJ (1983) Trifluperazine and chlorpromazine block secretion from human platelets evoked at basal cytoplasmic free calcium by activators of C-kinase. FEBS Lett 28:43
22. Wojtowicz Praga SM, Dickson RB, Hawkins MJ (1997) Matrix metalloproteinase inhibitors. Invest New Drugs 15:61
23. Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR (2003) Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study. Clin Cancer Res 9:109
24. Kato M, Liu W, Yi H, Asai N, Hayakawa A, Kozaki K, Takahashi M, Nakashima I (1998) The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice. J Invest Dermatol 111:640
25. Yan C, Han R (1997) Suppression of adhesion-induced protein tyrosine phosphorylation decreases invasive and metastatic potentials of B16-BL6 melanoma cells by protein tyrosine kinase inhibitor genistein. Invasion Metastasis 17:189
26. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M (1999) Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem 63:896
27. Paganga G, Miller N, Rice Evans CA (1999) The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? Free Radic Res 10:153
28. Zhang XM, Xu Q, Saiki I (2001) Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression. Clin Exp Metastasis 18:415
29. Sheng Y, Yoshimura M, Inoue S, Oritani K, Nishiura T, Yoshida H, Ogawa M, Okajima Y, Matsuzawa Y, Taniguchi N (1997) Remodeling glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing β-1,4-N-acetylgucosaminyltransferase III. Int J Cancer 73:850
30. Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswan C, Lee MT (2002) Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 22:1615
31. Kang TB, Liang NC (1997) Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54:1013
32. Igura K, Ohta T, Kuroda Y, Kija K (2001) Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171:11
33. Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Baker J, Kerr DJ (1996) Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2:659
34. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53:1649
35. Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D, Huryk R (1996) Overexpression of protein kinase C-zeta (PKC-zeta), inhibits invasive and metastatic abilities of Dunning R-3327 MAT-Lylu rat prostate cancer cells. Cancer Res 56:4137
36. Kiley SC, Clark KJ, Goodnough M, Welch DR, Jaken S (1999) Protein kinase C delta involvement in tumor cell metastasis. Cancer Res 59:3230
37. Dumont JA, Bitonti AJ (1994) Modulation of human melanoma cell metastasis and adhesion may involve integrin phosphorylation mediated through protein kinase C. Biochem Biophys Res Commun 204:264
38. Carey I, Williams CL, Ways DK, Noti JD (1999) Overexpression of protein kinase C-alpha in MCF-7 breast cancer cells results in differential regulation and expression of alphavbeta3 and alphavbeta5. Int J Oncol 5:127
39. Fichter M, Hinrichs R, Eissner G, Scheffer B, Classen S, Ueffing M (1997) Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C. Oncogene 14:2817
40. Quigley RL, Shafer SH, Williams CL (1998) Regulation of integrin-mediated adhesion by muscarinic acetylcholine receptors and protein kinase C in small cell carcinoma. Chest 114:839
41. Baba Y, Tsukuda M, Mochimatsu I, Furukawa S, Kagata H, Nagashima Y, Sakai N, Koshika S, Imoto M, Kato Y (2000) Inostamycin, an inhibitor of cytidine 5′-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and -9 and cell mobility in HSC-4 tongue carcinoma cell line. Clin Exp Metastasis 18:273